Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

48,551 stories, page 46 of 810

Advanced search

🇺🇰Oct 29Regulatorygov.ukTier 1 · Regulatory source

Respiratory syncytial virus (RSV): vaccination for older adults

Information on respiratory syncytial virus (RSV) and the benefits of vaccination for adults and reso...

UK Health Security AgencyOriginal source

🇺🇰Oct 29Regulatorygov.ukTier 1 · Regulatory source

Pneumococcal disease: cases caused by serotypes not covered by PCV13

Cumulative weekly data on invasive pneumococcal disease (IPD) infections due to serotypes not in Pre...

UK Health Security AgencyOriginal source

🇺🇰Oct 29Regulatorygov.ukTier 1 · Regulatory source

Pneumococcal disease: cases caused by serotypes covered by PCV13

Cumulative weekly data on invasive pneumococcal disease (IPD) infections due to serotypes in Prevena...

UK Health Security AgencyOriginal source

🌍Oct 29discoverynews.google.comTier 2 · Trade media

Ascletis’ challenger to Lilly’s Foundayo hits goals in phase 2 diabetes trial

Fierce BiotechOriginal source

🌍Oct 29discoverynews.google.comTier 3 · Aggregated media

Formation Bio launches USD 600 million fund to acquire and develop clinical-stage drugs

AllSciOriginal source

🇺🇸Oct 29Researchwi.mit.eduTier 2 · Direct publisher

Researchers create first whole-body single-cell atlas of an adult vertebrate

Whitehead Institute NewsOriginal source

🇸🇪Oct 29CDMOrecipharm.comTier 2 · Direct publisher

Recipharm reaches new heights with headquarters move to Switzerland

Recipharm PressOriginal source

🌍Oct 29discoverynews.google.comTier 3 · Aggregated media

Global drugmakers boost Korea trials, but China gains share and edge

ChosunbizOriginal source

🌍Oct 29discoverynews.google.comTier 3 · Aggregated media

China Resources Boya Bio-pharmaceutical Group: 9M revenue fell 42.54% as earnings slumped and focus shifted to blood products

TradingViewOriginal source

🌍Oct 29discoverynews.google.comTier 3 · Aggregated media

Zhejiang Huahai Pharmaceutical : 9M profit surged on business growth and significant non-recurring gains

TradingViewOriginal source

🌍Oct 29Researchkemri.go.keTier 2 · Direct publisher

KEMRI Becomes First African Member of the Global Dengue Alliance

KEMRI KenyaOriginal source

🌍Oct 29discoverynews.google.comTier 3 · Aggregated media

New COINS of the Realm: Treasury’s Implementation of COINS Act Reaches Biotech, AI, and More

Wilson SonsiniOriginal source

🌍Oct 29discoverynews.google.comTier 3 · Aggregated media

Hubei Jumpcan Pharmaceutical: Higher margins and adjusted profit offset softer 9M revenue and volatile investment results

TradingViewOriginal source

🌍Oct 29discoverynews.google.comTier 3 · Aggregated media

US bans imports from 3 Chinese biotech companies over forced labor allegations

WPTZOriginal source

🌍Oct 29discoverynews.google.comTier 3 · Aggregated media

Biotech Stocks Facing FDA Decision In November 2026

RTTNewsOriginal source

🌍Oct 29discoverynews.google.comTier 3 · Aggregated media

Access to peptides eased despite FDA opposition

Northwest Arkansas Democrat-GazetteOriginal source

🌍Oct 29discoverynews.google.comTier 3 · Aggregated media

The Catalan biotech Allox raises 9.4 million to boost its platform

Diari ARAOriginal source

🌍Oct 29discoverynews.google.comTier 2 · Trade media

Biopharma industry at odds over impact of Treasury’s new China rule

STATOriginal source

🇩🇪Oct 29pharma_equipmentsyntegon.comTier 2 · Direct publisher

PMEC India: shaping pharmaceutical manufacturing

Syntegon (Bosch Packaging)Original source

🌍Oct 29discoverynews.google.comTier 3 · Aggregated media

Daewon Pharmaceutical's P-CAB Drug Succeeds in Phase 3 Trial... Plans Approval Application This Year

아시아경제Original source

🌍Oct 29discoverynews.google.comTier 3 · Aggregated media

Jiangsu Jibeier Pharmaceutical: Q3 profit surged, while 9M adjusted earnings and operating cash flow advanced

TradingViewOriginal source

🌍Oct 29discoverynews.google.comTier 3 · Aggregated media

Takeda Pharmaceutical Raises FY2026 Outlook Amid Solid H1 Revenue Growth (TAK)

GuruFocusOriginal source

🌍Oct 29discoverynews.google.comTier 3 · Aggregated media

Daewon Pharmaceutical's Acid Reflux Drug Passes Phase 3 Trial

Seoul Economic DailyOriginal source

🌍Oct 29discoverynews.google.comTier 3 · Aggregated media

Takeda Pharmaceutical Company Limited (TAK) Reports Q3 EPS of JPY308.00; offers guidance

StreetInsiderOriginal source

🇯🇵Oct 29Industrysumitomo-pharma.comTier 1 · Company source

Posted Integrated Report 2026

Sumitomo PharmaOriginal source

🇺🇸Oct 29Industryelementbiosciences.comTier 1 · Company source

Element Biosciences Launches AVITI Dx™, Bringing CE-Marked IVD Sequencing to Ten EU Countries

Element BiosciencesOriginal source

🇪🇸Oct 29Researchclinicbarcelona.orgTier 2 · Direct publisher

El Clínic receives a #PorElClima Healthcare Award for its strategy to reduce the environmental impact of dialysis

Hospital Clínic de BarcelonaOriginal source

🌍Oct 29discoverynews.google.comTier 3 · Aggregated media

Takeda Pharmaceutical H1 Core Earnings, Revenue Rise; 2026 Guidance Lifted

Yahoo FinanceOriginal source

🌍Oct 29Industryamarin.co.thTier 3 · Secondary coverage

AMARIN คว้า CG Rating ระดับ 5 ดาว ต่อเนื่องปีที่ 5

Amarin CorporationOriginal source

🌍Oct 29discoverynews.google.comTier 3 · Aggregated media

BioVersys announces first patient first visit in Phase 2b RIV-CARE trial of BV100

DagangNewsOriginal source

🌍Oct 29discoverynews.google.comTier 3 · Aggregated media

BioVersys announces first patient first visit in Phase 2b RIV-CARE trial of BV100

The Manila TimesOriginal source

🌍Oct 29discoverynews.google.comTier 3 · Aggregated media

Takeda Pharmaceutical Raises Annual Guidance

marketscreener.comOriginal source

🌍Oct 29discoverynews.google.comTier 3 · Aggregated media

Moscow and Managua deepen pharmaceutical partnership at congress in Nicaragua

Новости GxPOriginal source

🌍Oct 29discoverynews.google.comTier 3 · Aggregated media

U.S. Restricts Trade With Chinese Genomics Company

The New York TimesOriginal source

🇸🇪Oct 29Industrysobi.comTier 1 · Company source

Late-breaking Phase 3 REDUCE-2 data show clinically meaningful and durable serum urate lowering with pozdeutinurad

Detailed efficacy and safety results from the pivotal phase 3 study demonstrate statistically signif...

Swedish Orphan BiovitrumOriginal source

🌍Oct 29discoverynews.google.comTier 3 · Aggregated media

Top 10 Agitated Nutsche Filter Dryer Manufacturers in 2026: Advancing Pharmaceutical Production

EIN NewsOriginal source

🌍Oct 29discoverynews.google.comTier 3 · Aggregated media

Chugai Pharmaceutical (TSE:4519) Stock Price Trails Strong Q3 Earnings

Yahoo FinanceOriginal source

🌍Oct 29discoverynews.google.comTier 3 · Aggregated media

US bans imports from 3 Chinese biotech companies over forced labor allegations

The HillOriginal source

🌍Oct 29discoverynews.google.comTier 3 · Aggregated media

US bans imports from 3 Chinese biotech companies over forced labor allegations

AP NewsOriginal source

🌍Oct 29discoverynews.google.comTier 3 · Aggregated media

FDA-Approved Antibody-Drug Conjugates Reshape Blood Cancer Treatment

Bioengineer.orgOriginal source

🌍Oct 29discoverynews.google.comTier 3 · Aggregated media

PM says to foster 200 'frontier' bio, pharmaceutical firms by 2030

The Korea HeraldOriginal source

🌍Oct 29discoverynews.google.comTier 3 · Aggregated media

PPH: Key Pharmaceutical Innovations Support Bullish Outlook (Upgrade)

Seeking AlphaOriginal source

🌍Oct 29discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical spending linked to lower treatable deaths in Spain

Bioengineer.orgOriginal source

🇯🇵Oct 29Researchjsmo.or.jpTier 2 · Direct publisher

医薬品・医療機器等安全性情報 No.433（厚生労働省）

Japanese Society of Medical OncologyOriginal source

🌍Oct 29discoverynews.google.comTier 3 · Aggregated media

Inside Biotech: Mesoblast surges 24% as Ryoncil sales climb and cash spend falls sharply

Yahoo Finance AustraliaOriginal source

🌍Oct 29discoverynews.google.comTier 3 · Aggregated media

Korea’s First Homegrown Obesity Drug Begins Prescriptions, Challenging Mounjaro on Price

BusinesskoreaOriginal source

🇺🇸Oct 29Regulatoryfda.govTier 1 · Regulatory source

Early Alert: Medline Removes or Corrects All Medline Brand Beds and Accessories

Medline removes or corrects all brand beds & accessories due to fire, electrical overheating, entrap...

FDA MedWatchOriginal source

🌍Oct 29discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical Industry in Crisis: A Threat to Public Health

Pressenza - International Press AgencyOriginal source

🇺🇸Oct 29Researchonlinelibrary.wiley.comTier 2 · Direct publisher

Concomitant Aveir AR and Micra AV2 Hybrid Leadless Implantation During Infected Pacemaker Extraction

Pacing and Clinical ElectrophysiologyOriginal source

🇺🇸Oct 29Researchonlinelibrary.wiley.comTier 2 · Direct publisher

Insertable Cardiac Monitoring in Pediatric Patients: A Real‐World Single‐Center Experience With a New‐Generation Device

Pacing and Clinical ElectrophysiologyOriginal source

🇺🇸Oct 29Researchonlinelibrary.wiley.comTier 2 · Direct publisher

Feasibility of Left Bundle Branch Pacing and Management of Jailed Leads After Transcatheter Tricuspid Valve Implantation

Pacing and Clinical ElectrophysiologyOriginal source

🌍Oct 29discoverynews.google.comTier 3 · Aggregated media

RFK Jr. plans to make 6 unapproved peptides available for temporary sale

The Washington PostOriginal source

🌍Oct 29discoverynews.google.comTier 3 · Aggregated media

SciVision Biotech's Drug-Containing Hyaluronic Acid Filler Wins China Class III Medical Device Certificate; Shares Gap Up and Lock at Limit-High NT$43.25

BigGo FinanceOriginal source

🌍Oct 29discoverynews.google.comTier 3 · Aggregated media

Ono Pharmaceutical : Revenue fell 9.6%, but core operating profit rose 5.1%

TradingViewOriginal source

🇯🇵Oct 29Regulatorypmda.go.jpTier 1 · Regulatory source

[SHINSA]English Translation of Review Report: Zurzuvae

PMDA JapanOriginal source

🌍Oct 29discoverynews.google.comTier 3 · Aggregated media

FDA Clarifies Regulatory Standards for Prescription Drug Apps, Including Device-Linked and Standalone Software

헬스조선Original source

🌍Oct 29discoverynews.google.comTier 3 · Aggregated media

Protina Secures Osteoarthritis Drug Patents in 8 Countries; Due Diligence Underway with 2 Japanese Pharma Companies for Licensing Deal

BigGo FinanceOriginal source

🇺🇸Oct 29Industrythefdalawblog.comTier 3 · Secondary coverage

The Flexibility Papers, No. 1: First Principles for a Rare Disease Framework

Hyman, Phelps & McNamara (FDA Law)Original source

🌍Oct 29discoverynews.google.comTier 3 · Aggregated media

US bans imports from 3 Chinese biotech companies over forced labor allegations

The MercuryOriginal source

🌍Oct 29discoverynews.google.comTier 3 · Aggregated media

HHS Plan for Peptide Drug Access Faces FDA Opposition Amid Safety Concerns

SSBCrackOriginal source